HSP70 Multi-Functionality in Cancer

Ritossa, 1962, A new puffing pattern induced by temperature shock and DNP in drosophila, Cell. Mol. Life Sci., 18, 571, 10.1007/BF02172188

Mitchell, 1974, Protein synthesis in salivary glands of Drosophila melanogaster: Relation to chromosome puffs, J. Mol. Biol., 84, 389, 10.1016/0022-2836(74)90447-1

Moran, 1978, Heat shock of Drosophila melanogaster induces the synthesis of new messenger RNAs and proteins, Philos. Trans. R. Soc. B Biol. Sci., 283, 391

Daugaard, 2007, The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions, FEBS Lett., 581, 3702, 10.1016/j.febslet.2007.05.039

Beere, 2001, Stress management—Heat shock protein-70 and the regulation of apoptosis, Trends Cell Biol., 11, 6, 10.1016/S0962-8924(00)01874-2

Yang, 2012, Hsp70 promotes chemoresistance by blocking Bax mitochondrial translocation in ovarian cancer cells, Cancer Lett., 321, 137, 10.1016/j.canlet.2012.01.030

Pelham, 1984, Hsp70 accelerates the recovery of nucleolar morphology after heat shock, EMBO J., 3, 3095, 10.1002/j.1460-2075.1984.tb02264.x

Rosenzweig, 2019, The Hsp70 chaperone network, Nat. Rev. Mol. Cell Biol., 20, 665, 10.1038/s41580-019-0133-3

Hunt, 1985, Conserved features of eukaryotic hsp70 genes revealed by comparison with the nucleotide sequence of human hsp70, Proc. Natl. Acad. Sci. USA, 82, 6455, 10.1073/pnas.82.19.6455

Lindquist, 1988, The heat-shock proteins, Annu. Rev. Genet., 22, 631, 10.1146/annurev.ge.22.120188.003215

Gupta, 1994, Phylogenetic analysis of 70 kD heat shock protein sequences suggests a chimeric origin for the eukaryotic cell nucleus, Curr. Biol., 4, 1104, 10.1016/S0960-9822(00)00249-9

Mosser, 2004, Molecular chaperones and the stress of oncogenesis, Oncogene, 23, 2907, 10.1038/sj.onc.1207529

Ciocca, 2005, Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications, Cell Stress Chaperones, 10, 86, 10.1379/CSC-99r.1

Calderwood, 2006, Heat shock proteins in cancer: Chaperones of tumorigenesis, Trends Biochem. Sci., 31, 164, 10.1016/j.tibs.2006.01.006

Hanahan, 2011, Hallmarks of cancer: The next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013

Kampinga, 2010, The HSP70 chaperone machinery: J proteins as drivers of functional specificity, Nat. Rev. Mol. Cell Biol., 11, 579, 10.1038/nrm2941

Arakawa, 2010, The C-Terminal BAG Domain of BAG5 Induces Conformational Changes of the Hsp70 Nucleotide- Binding Domain for ADP-ATP Exchange, Structure, 18, 309, 10.1016/j.str.2010.01.004

Arakawa, 2011, Biochemical and structural studies on the high affinity of Hsp70 for ADP, Protein Sci., 20, 1367, 10.1002/pro.663

Cheeseman, 2016, Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70, J. Med. Chem., 59, 4625, 10.1021/acs.jmedchem.5b02001

Gao, 2012, The C-terminal Helices of Heat Shock Protein 70 Are Essential for J-domain Binding and ATPase Activation*, J. Biol. Chem., 287, 6044, 10.1074/jbc.M111.294728

Hassan, 2015, The Novolactone Natural Product Disrupts the Allosteric Regulation of Hsp70, Chem. Biol., 22, 87, 10.1016/j.chembiol.2014.11.007

Jones, 2016, A fragment-based approach applied to a highly flexible target: Insights and challenges towards the inhibition of HSP70 isoforms, Sci. Rep., 6, 34701, 10.1038/srep34701

Lim, 2019, Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development, Nat. Methods, 16, 31, 10.1038/s41589-019-0415-2

Osipiuk, 1999, Structure of a new crystal form of human Hsp70 ATPase domain, Acta Crystallogr. Sect. D Biol. Crystallogr., 55, 1105, 10.1107/S0907444999002103

Ravalin, 2019, Specificity for latent C termini links the E3 ubiquitin ligase CHIP to caspases, Nat. Methods, 15, 786, 10.1038/s41589-019-0322-6

Shida, 2010, Direct inter-subdomain interactions switch between the closed and open forms of the Hsp70 nucleotide-binding domain in the nucleotide-free state, Acta Crystallogr. Sect. D Biol. Crystallogr., 66, 223, 10.1107/S0907444909053979

Sriram, 1997, Human Hsp70 molecular chaperone binds two calcium ions within the ATPase domain, Structure, 5, 403, 10.1016/S0969-2126(97)00197-4

Umehara, K., Hoshikawa, M., Tochio, N., and Tate, S.-I. (2018). Substrate Binding Switches the Conformation at the Lynchpin Site in the Substrate-Binding Domain of Human Hsp70 to Enable Allosteric Interdomain Communication. Molecules, 23.

Zhang, P., Leu, J.I.-J., Murphy, M.E., George, D.L., and Marmorstein, R. (2014). Crystal Structure of the Stress-Inducible Human Heat Shock Protein 70 Substrate-Binding Domain in Complex with Peptide Substrate. PLoS ONE, 9.

Murphy, 2013, The HSP70 family and cancer, Carcinogen, 34, 1181, 10.1093/carcin/bgt111

Ha, 1995, Kinetics of Nucleotide-Induced Changes in the Tryptophan Fluorescence of the Molecular Chaperone Hsc70 and Its Subfragments Suggest the ATP-Induced Conformational Change Follows Initial ATP Binding, Biochemistry, 34, 11635, 10.1021/bi00036a040

Palleros, 1993, ATP-induced protein Hsp70 complex dissociation requires K+ but not ATP hydrolysis, Nature, 365, 664, 10.1038/365664a0

Schmid, 1994, Kinetics of molecular chaperone action, Science, 263, 971, 10.1126/science.8310296

Prasad, 1994, Complex formation between clathrin and uncoating ATPase, J. Biol. Chem., 269, 6931, 10.1016/S0021-9258(17)37464-1

Hartl, 1996, Molecular chaperones in cellular protein folding, Nature, 381, 571, 10.1038/381571a0

Laufen, 1999, Mechanism of regulation of Hsp70 chaperones by DnaJ cochaperones, Proc. Natl. Acad. Sci. USA, 96, 5452, 10.1073/pnas.96.10.5452

Mayer, 2005, Hsp70 chaperones: Cellular functions and molecular mechanism, Cell. Mol. Life Sci., 62, 670, 10.1007/s00018-004-4464-6

Suzuki, 2010, Peptide-Binding Sites As Revealed by the Crystal Structures of the Human Hsp40 Hdj1 C-Terminal Domain in Complex with the Octapeptide from Human Hsp70, Biochemistry, 49, 8577, 10.1021/bi100876n

Jiang, 2019, Structural basis for client recognition and activity of Hsp40 chaperones, Science, 365, 1313, 10.1126/science.aax1280

Craig, E., Huang, P., Aron, R., and Andrew, A. (2006). The diverse roles of J-proteins, the obligate Hsp70 co-chaperone. Ergeb. der Physiol., 156.

Hageman, 2008, Computational analysis of the human HSPH/HSPA/DNAJ family and cloning of a human HSPH/HSPA/DNAJ expression library, Cell Stress Chaperones, 14, 1, 10.1007/s12192-008-0060-2

Diamant, 1998, Temperature-Controlled Activity of DnaK−DnaJ−GrpE Chaperones: Protein-Folding Arrest and Recovery during and after Heat Shock Depends on the Substrate Protein and the GrpE Concentration†, Biochemistry, 37, 9688, 10.1021/bi980338u

Mitra, 2009, Multi-faceted role of HSP40 in cancer, Clin. Exp. Metastasis, 26, 559, 10.1007/s10585-009-9255-x

Bracher, 2015, The nucleotide exchange factors of Hsp70 molecular chaperones, Front. Mol. Biosci., 2, 10, 10.3389/fmolb.2015.00010

Brodsky, J.L., and Bracher, A. (2007). Nucleotide Exchange Factors for HSP70 Molecular Chaperones. Networking of Chaperones by Co-Chaperones, Springer. Molecular Biology Intelligence Unit.

Li, 2013, Structure and function of Hip, an attenuator of the Hsp70 chaperone cycle, Nat. Struct. Mol. Biol., 20, 929, 10.1038/nsmb.2608

Wang, 2012, Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation, Nat. Methods, 9, 112, 10.1038/nchembio.1140

Rousaki, 2011, Allosteric Drugs: The Interaction of Antitumor Compound MKT-077 with Human Hsp70 Chaperones, J. Mol. Biol., 411, 614, 10.1016/j.jmb.2011.06.003

Scheufler, 2000, Structure of TPR Domain–Peptide Complexes, Cell, 101, 199, 10.1016/S0092-8674(00)80830-2

Smith, 1993, Identification of a 60-kilodalton stress-related protein, p60, which interacts with hsp90 and hsp70, Mol. Cell. Biol., 13, 869

Leffers, 1992, Molecular cloning and expression of a transformation-sensitive human protein containing the TPR motif and sharing identity to the stress-inducible yeast protein STI1, J. Biol. Chem., 267, 8485, 10.1016/S0021-9258(18)42471-4

Stankiewicz, 2010, CHIP participates in protein triage decisions by preferentially ubiquitinating Hsp70-bound substrates, FEBS J., 277, 3353, 10.1111/j.1742-4658.2010.07737.x

Cyr, 2001, From the cradle to the grave: Molecular chaperones that may choose between folding and degradation, EMBO Rep., 2, 885, 10.1093/embo-reports/kve206

Connell, 2000, The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins, Nature, 3, 93

Meacham, 2000, The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation, Nature, 3, 100

Ballinger, 1999, Identification of CHIP, a Novel Tetratricopeptide Repeat-Containing Protein That Interacts with Heat Shock Proteins and Negatively Regulates Chaperone Functions, Mol. Cell. Biol., 19, 4535, 10.1128/MCB.19.6.4535

Zhang, 2015, A Bipartite Interaction between Hsp70 and CHIP Regulates Ubiquitination of Chaperoned Client Proteins, Structure, 23, 472, 10.1016/j.str.2015.01.003

Neckers, 2012, Hsp90 molecular chaperone inhibitors: Are we there yet?, Clin. Cancer Res., 18, 64, 10.1158/1078-0432.CCR-11-1000

Schopf, 2017, The HSP90 chaperone machinery, Nat. Rev. Mol. Cell. Biol., 18, 345, 10.1038/nrm.2017.20

Miyata, 2013, The therapeutic target Hsp90 and cancer hallmarks, Curr. Pharm. Des., 19, 347, 10.2174/138161213804143725

Rodina, 2016, The epichaperome is an integrated chaperome network that facilitates tumour survival, Nature, 538, 397, 10.1038/nature19807

Bromberg, 2016, The Role of the Membrane-Initiated Heat Shock Response in Cancer, Front. Mol. Biosci., 3, 545, 10.3389/fmolb.2016.00012

Shevtsov, 2017, Membrane heat shock protein 70: A theranostic target for cancer therapy, Philos. Trans. R. Soc. B Biol. Sci., 373, 20160526, 10.1098/rstb.2016.0526

Shin, 2002, Global Profiling of the Cell Surface Proteome of Cancer Cells Uncovers an Abundance of Proteins with Chaperone Function, J. Biol. Chem., 278, 7607, 10.1074/jbc.M210455200

Multhoff, 1995, A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells, but not on normal cells, Int. J. Cancer, 61, 272, 10.1002/ijc.2910610222

Lauwers, 2018, Hsp90 Mediates Membrane Deformation and Exosome Release, Mol. Cell, 71, 689, 10.1016/j.molcel.2018.07.016

Gastpar, 2005, Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells, Cancer Res., 65, 5238, 10.1158/0008-5472.CAN-04-3804

Guzhova, 2013, Intracellular and extracellular Hsp70 chaperone as a target for cancer therapy, Int. J. Hyperth., 29, 399, 10.3109/02656736.2013.807439

Clayton, 2005, Induction of heat shock proteins in B-cell exosomes, J. Cell Sci., 118, 3631, 10.1242/jcs.02494

Lancaster, 2005, Exosome-dependent trafficking of HSP70: A novel secretory pathway for cellular stress proteins, J. Biol. Chem., 280, 23349, 10.1074/jbc.M502017200

Mambula, 2007, Mechanisms for Hsp70 secretion: Crossing membranes without a leader, Methods, 43, 168, 10.1016/j.ymeth.2007.06.009

Juhasz, 2013, Lysosomal Rerouting of Hsp70 Trafficking as a Potential Immune Activating Tool for Targeting Melanoma, Curr. Pharm. Des., 19, 430, 10.2174/138161213804143644

Balogi, 2019, Hsp70 interactions with membrane lipids regulate cellular functions in health and disease, Prog. Lipid Res., 74, 18, 10.1016/j.plipres.2019.01.004

Murakami, 2015, Role of membrane Hsp70 in radiation sensitivity of tumor cells, Radiat. Oncol., 10, 149, 10.1186/s13014-015-0461-1

Gehrmann, M., Liebisch, G., Schmitz, G., Anderson, R., Steinem, C., De Maio, A., Pockley, A.G., and Multhoff, G. (2008). Tumor-Specific Hsp70 Plasma Membrane Localization Is Enabled by the Glycosphingolipid Gb3. PLoS ONE, 3.

Vega, 2008, Hsp70 Translocates into the Plasma Membrane after Stress and Is Released into the Extracellular Environment in a Membrane-Associated Form that Activates Macrophages, J. Immunol., 180, 4299, 10.4049/jimmunol.180.6.4299

Arispe, 2004, Hsc70 and Hsp70 interact with phosphatidylserine on the surface of PC12 cells resulting in a decrease of viability, FASEB J., 18, 1636, 10.1096/fj.04-2088com

Mamelak, 2001, The ATPase Domain of hsp70 Possesses a Unique Binding Specificity for 3′-Sulfogalactolipids, J. Biol.Chem., 276, 449, 10.1074/jbc.M006732200

Asea, 2000, HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine, Nat. Med., 6, 435, 10.1038/74697

Asea, 2002, Novel Signal Transduction Pathway Utilized by Extracellular HSP70. Role of Toll-Like Receptor (TLR) 2 and TLR4, J. Biol. Chem., 277, 15028, 10.1074/jbc.M200497200

Vabulas, 2002, HSP70 as Endogenous Stimulus of the Toll/Interleukin-1 Receptor Signal Pathway, J. Biol. Chem., 277, 15107, 10.1074/jbc.M111204200

Delneste, 2002, Involvement of LOX-1 in Dendritic Cell-Mediated Antigen Cross-Presentation, Immunity, 17, 353, 10.1016/S1074-7613(02)00388-6

Mambula, 2005, Extracellular HSP70 binding to surface receptors present on antigen presenting cells and endothelial/epithelial cells, FEBS Lett., 579, 1951, 10.1016/j.febslet.2005.02.046

Basu, 2001, CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin, Immunity, 14, 303, 10.1016/S1074-7613(01)00111-X

Becker, 2002, CD40, an extracellular receptor for binding and uptake of Hsp70–peptide complexes, J. Cell Biol., 158, 1277, 10.1083/jcb.200208083

Somensi, 2017, Extracellular HSP70 Activates ERK1/2, NF-kB and Pro-Inflammatory Gene Transcription Through Binding with RAGE in A549 Human Lung Cancer Cells, Cell. Physiol. Biochem., 42, 2507, 10.1159/000480213

Hromadníková, I., Li, S., Kotlabova, K., and Dickinson, A.M. (2016). Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp 70 Derived 14-Mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors on Peripheral Blood T Cells, B Cells and NKT Cells. PLoS ONE, 11.

Stangl, 2008, Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells, Cell Stress Chaperones, 13, 221, 10.1007/s12192-007-0008-y

Gross, C., Hansch, D., Gastpar, R., and Multhoff, G. (2003). Interaction of Heat Shock Protein 70 Peptide with NK Cells Involves the NK Receptor CD94. Biol. Chem., 384.

An, 2011, Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation*, J. Biol. Chem., 286, 11226, 10.1074/jbc.M110.208215

Argiriadi, 2019, CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches, BMC Mol. Cell Biol., 20, 13, 10.1186/s12860-019-0213-4

Basu, 2019, Design, Synthesis, Evaluation, and Structural Studies of C2-Symmetric Small Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein-Protein Interaction, J. Med. Chem., 62, 7250, 10.1021/acs.jmedchem.9b00795

Cheng, 2016, A near atomic structure of the active human apoptosome, eLife, 5, 423, 10.7554/eLife.17755

Deng, 2007, Structural basis for the recognition of mutant self by a tumor-specific, MHC class II–restricted T cell receptor, Nat. Immunol., 8, 398, 10.1038/ni1447

Dong, 2019, Structural basis of assembly of the human T cell receptor-CD3 complex, Nature, 573, 546, 10.1038/s41586-019-1537-0

Evans, 2005, Crystal structure of a soluble CD28-Fab complex, Nat. Immunol., 6, 271, 10.1038/ni1170

Forneris, 2016, Regulators of complement activity mediate inhibitory mechanisms through a common C3b-binding mode, EMBO J., 35, 1133, 10.15252/embj.201593673

Ikemizu, 2000, Structure and dimerization of a soluble form of B7-1, Immunity, 12, 51, 10.1016/S1074-7613(00)80158-2

Leahy, 1992, Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 Å resolution, Cell, 68, 1145, 10.1016/0092-8674(92)90085-Q

Hirabayashi, 2004, Growth-regulatory Human Galectin-1: Crystallographic Characterisation of the Structural Changes Induced by Single-site Mutations and their Impact on the Thermodynamics of Ligand Binding, J. Mol. Biol., 343, 957, 10.1016/j.jmb.2004.08.078

Madden, 1993, The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2, Cell, 75, 693, 10.1016/0092-8674(93)90490-H

McFarland, B.J., Kortemme, T., Yu, S.F., Baker, D., and Strong, R. (2003). Symmetry recognizing asymmetry: Analysis of the interactions between the C-type lectin-like immunoreceptor NKG2D and MHC class I-like ligands. Structure, 11.

Park, 2009, The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex, Nature, 458, 1191, 10.1038/nature07830

Porter, 2009, Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors, Bioorganic Med. Chem. Lett., 19, 230, 10.1016/j.bmcl.2008.10.113

Santiago, 2009, Structure of the measles virus hemagglutinin bound to the CD46 receptor, Nat. Struct. Mol. Biol., 17, 124, 10.1038/nsmb.1726

Schulze, M.-S.E.D., Anders, A.-K., Sethi, D.K., and Call, M. (2013). Disruption of Hydrogen Bonds between Major Histocompatibility Complex Class II and the Peptide N-Terminus Is Not Sufficient to Form a Human Leukocyte Antigen-DM Receptive State of Major Histocompatibility Complex Class II. PLoS ONE, 8.

Sharif, 2019, Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome, Nature, 570, 338, 10.1038/s41586-019-1295-z

Lohr, 2010, N-domain of human adhesion/growth-regulatory galectin-9: Preference for distinct conformers and non-sialylated N-glycans and detection of ligand-induced structural changes in crystal and solution, Int. J. Biochem. Cell Biol., 42, 1019, 10.1016/j.biocel.2010.03.007

Su, 2019, Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim, J. Med. Chem., 62, 2938, 10.1021/acs.jmedchem.8b01583

Sullivan, 2007, The Heterodimeric Assembly of the CD94-NKG2 Receptor Family and Implications for Human Leukocyte Antigen-E Recognition, Immunity, 27, 900, 10.1016/j.immuni.2007.10.013

Wu, 1996, Kinetic and structural analysis of mutant CD4 receptors that are defective in HIV gp120 binding, Proc. Natl. Acad. Sci. USA, 93, 15030, 10.1073/pnas.93.26.15030

Yoshida, 2010, X-ray Structures of Human Galectin-9 C-terminal Domain in Complexes with a Biantennary Oligosaccharide and Sialyllactose*, J. Biol. Chem., 285, 36969, 10.1074/jbc.M110.163402

Zhang, 2003, Crystal structure of the receptor-binding domain of human B7-2: Insights into organization and signaling, Proc. Natl. Acad. Sci. USA, 100, 2586, 10.1073/pnas.252771499

Fedorov, A., Fedorov, E., Samanta, D., Hillerich, B., Seidel, R., and Almo, S. (2020, January 01). Crystal Structure of T Cell Costimulatory Ligand B7-1 (CD80). Available online: http://www.rcsb.org/structure/4RWH.

Le Nours, J., and Rossjohn, J. (2020, January 01). Recognition of MHC-Like Molecule 2019. Available online: https://www.rcsb.org/structure/6MWR.

Pierce, B., Hourai, Y., and Weng, Z. (2011). Accelerating Protein Docking in ZDOCK Using an Advanced 3D Convolution Library. PLoS ONE, 6.

Pierce, 2007, ZRANK: Reranking protein docking predictions with an optimized energy function, Proteins Struct. Funct. Bioinform., 67, 1078, 10.1002/prot.21373

Hanahan, 2000, The Hallmarks of Cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9

Srivastava, 2002, Interaction of Heat Shock Proteins with Peptides and Antigen Presenting Cells: Chaperoning of the Innate and Adaptive Immune Responses, Annu. Rev. Immunol., 20, 395, 10.1146/annurev.immunol.20.100301.064801

Blachere, 1997, Heat Shock Protein–Peptide Complexes, Reconstituted In Vitro, Elicit Peptide-specific Cytotoxic T Lymphocyte Response and Tumor Immunity, J. Exp. Med., 186, 1315, 10.1084/jem.186.8.1315

Multhoff, 2001, A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity, Cell Stress Chaperons, 6, 337, 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2

Multhoff, 1997, Heat shock protein 72 on tumor cells: A recognition structure for natural killer cells, J. Immunol., 158, 4341, 10.4049/jimmunol.158.9.4341

Multhoff, 1999, Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells, Exp. Hematol., 27, 1627, 10.1016/S0301-472X(99)00104-6

Specht, H.M., Ahrens, N., Blankenstein, C., Duell, T., Fietkau, R., Gaipl, U.S., Günther, C., Gunther, S., Habl, G., and Hautmann, H. (2015). Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial. Front. Immunol., 6.

Deloch, 2018, Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies, Strahlenther. und Onkol., 194, 509, 10.1007/s00066-018-1287-1

Ostheimer, 2015, Correlation of Hsp70 Serum Levels with Gross Tumor Volume and Composition of Lymphocyte Subpopulations in Patients with Squamous Cell and Adeno Non-Small Cell Lung Cancer, Front. Immunol., 6, 128

Ostheimer, C., Gunther, S., Bache, M., Vordermark, D., and Multhoff, G. (2017). Dynamics of Heat Shock Protein 70 Serum Levels As a Predictor of Clinical Response in Non-Small-Cell Lung Cancer and Correlation with the Hypoxia-Related Marker Osteopontin. Front. Immunol., 8.

Diaz, 2004, A simple method to cure established tumors by inflammatory killing of normal cells, Nat. Biotechnol., 22, 1125, 10.1038/nbt1007

Breloer, M., Fleischer, B., and Von Bonin, A. (1999). In vivo and in vitro activation of T cells after administration of Ag-negative heat shock proteins. J. Immunol., 162.

Rothammer, 2019, Increased heat shock protein 70 (Hsp70) serum levels and low NK cell counts after radiotherapy - potential markers for predicting breast cancer recurrence?, Radiat. Oncol., 14, 78, 10.1186/s13014-019-1286-0

Pfister, 2007, Patient survival by Hsp70 membrane phenotype, Cancer, 110, 926, 10.1002/cncr.22864

Zininga, T., Ramatsui, L., and Shonhai, A. (2018). Heat Shock Proteins as Immunomodulants. Molecules, 23.

Wachstein, J., Tischer, S., Figueiredo, C., Limbourg, A., Falk, C., Immenschuh, S., Blasczyk, R., and Eiz-Vesper, B. (2012). HSP70 Enhances Immunosuppressive Function of CD4+CD25+FoxP3+ T Regulatory Cells and Cytotoxicity in CD4+CD25− T Cells. PLoS ONE, 7.

Asea, 2006, Initiation of the Immune Response by Extracellular Hsp72: Chaperokine Activity of Hsp72, Curr. Immunol. Rev., 2, 209, 10.2174/157339506778018514

Asea, 2003, Chaperokine-induced signal transduction pathways, Exerc. Immunol. Rev., 9, 25

Martine, 2019, HSP70 is a negative regulator of NLRP3 inflammasome activation, Cell Death Dis., 10, 256, 10.1038/s41419-019-1491-7

Moossavi, 2018, Role of the NLRP3 inflammasome in cancer, Mol. Cancer, 17, 158, 10.1186/s12943-018-0900-3

Yashin, 2016, The Tag7–Hsp70 cytotoxic complex induces tumor cell necroptosis via permeabilisation of lysosomes and mitochondria, Biochimie, 123, 32, 10.1016/j.biochi.2016.01.007

Sashchenko, 2003, Peptidoglycan Recognition Protein Tag7 Forms a Cytotoxic Complex with Heat Shock Protein 70 in Solution and in Lymphocytes, J. Biol. Chem., 279, 2117, 10.1074/jbc.M307513200

Chalmin, 2010, Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells, J. Clin. Investig., 120, 457

Bausero, 2005, Alternative Mechanism by which IFN-γ Enhances Tumor Recognition: Active Release of Heat Shock Protein 721, J. Immunol., 175, 2900, 10.4049/jimmunol.175.5.2900

Orditura, 1999, Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies, Cancer, 86, 1936, 10.1002/(SICI)1097-0142(19991115)86:10<1936::AID-CNCR9>3.0.CO;2-9

Lebrecht, 2001, Serum Cytokine Concentrations in Patients with Cervical Cancer: Interleukin-4, Interferon-γ, and Monocyte Chemoattractant Protein-1, Gynecol. Oncol., 83, 170, 10.1006/gyno.2001.6361

Udono, 1994, Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70, J. Immunol., 152, 5398, 10.4049/jimmunol.152.11.5398

Weng, 2011, Preparation of a heat-shock protein 70-based vaccine from DC-tumor fusion cells, Breast Cancer, 787, 255

Hegde, 2020, Top 10 Challenges in Cancer Immunotherapy, Immunity, 52, 17, 10.1016/j.immuni.2019.12.011

Calderwood, 2017, Molecular Chaperone Accumulation in Cancer and Decrease in Alzheimer’s Disease: The Potential Roles of HSF1, Front. Neurosci., 11, 192, 10.3389/fnins.2017.00192

Mosser, 1997, Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis, Mol. Cell. Biol., 17, 5317, 10.1128/MCB.17.9.5317

Nylandsted, 2000, Selective depletion of heat shock protein 70 (Hsp70) activates a tumor-specific death program that is independent of caspases and bypasses Bcl-2, Proc. Natl. Acad. Sci. USA, 97, 7871, 10.1073/pnas.97.14.7871

Gao, 2010, Heat shock protein 70 together with its co-chaperone CHIP inhibits TNF-α induced apoptosis by promoting proteasomal degradation of apoptosis signal-regulating kinase1, Apoptosis, 15, 822, 10.1007/s10495-010-0495-7

Tournier, 2000, Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death Pathway, Science, 288, 870, 10.1126/science.288.5467.870

Dhanasekaran, 2008, JNK signaling in apoptosis, Oncogene, 27, 6245, 10.1038/onc.2008.301

Sax, 2002, BID regulation by p53 contributes to chemosensitivity, Nature, 4, 842

Ravagnan, 2001, Heat-shock protein 70 antagonizes apoptosis-inducing factor, Nature, 3, 839

Guo, 2005, Mechanistic role of heat shock protein 70 in Bcr-Abl–mediated resistance to apoptosis in human acute leukemia cells, Blood, 105, 1246, 10.1182/blood-2004-05-2041

Gabai, 2002, Hsp72 and Stress Kinase c-jun N-Terminal Kinase Regulate the Bid-Dependent Pathway in Tumor Necrosis Factor-Induced Apoptosis, Mol. Cell. Biol., 22, 3415, 10.1128/MCB.22.10.3415-3424.2002

Nylandsted, 2004, Heat Shock Protein 70 Promotes Cell Survival by Inhibiting Lysosomal Membrane Permeabilization, J. Exp. Med., 200, 425, 10.1084/jem.20040531

Bivik, 2006, Hsp70 protects against UVB induced apoptosis by preventing release of cathepsins and cytochrome c in human melanocytes, Carcinogen, 28, 537, 10.1093/carcin/bgl152

Daugaard, 2007, Lens Epithelium-Derived Growth Factor Is an Hsp70-2 Regulated Guardian of Lysosomal Stability in Human Cancer, Cancer Res., 67, 2559, 10.1158/0008-5472.CAN-06-4121

Park, 2018, Subcellular Hsp70 Inhibitors Promote Cancer Cell Death via Different Mechanisms, Cell Chem. Biol., 25, 1242, 10.1016/j.chembiol.2018.06.010

Yaglom, 2003, Regulation of Necrosis of H9c2 Myogenic Cells upon Transient Energy Deprivation, J. Biol. Chem., 278, 50483, 10.1074/jbc.M306903200

Feiglin, 2018, Tissue necrosis and its role in cancer progression, Oncogene, 38, 1920

Stankiewicz, 2005, Hsp70 Inhibits Heat-induced Apoptosis Upstream of Mitochondria by Preventing Bax Translocation, J. Biol. Chem., 280, 38729, 10.1074/jbc.M509497200

Beere, 2000, Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome, Nature, 2, 469

Yaglom, 2007, High Levels of Heat Shock Protein Hsp72 in Cancer Cells Suppress Default Senescence Pathways, Cancer Res., 67, 2373, 10.1158/0008-5472.CAN-06-3796

Gabai, 2008, Heat Shock Protein Hsp72 Controls Oncogene-Induced Senescence Pathways in Cancer Cells, Mol. Cell. Biol., 29, 559, 10.1128/MCB.01041-08

Meng, 2011, Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis, Oncogene, 30, 2836, 10.1038/onc.2011.5

Colvin, 2014, Hsp70-Bag3 interactions regulate cancer-related signaling networks, Cancer Res., 74, 4731, 10.1158/0008-5472.CAN-14-0747

Meng, 2010, Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis, Oncogene, 29, 5204, 10.1038/onc.2010.277

Oda, 2018, Acute HSF1 depletion induces cellular senescence through the MDM2-p53-p21 pathway in human diploid fibroblasts, J. Cell Sci., 131, jcs210724, 10.1242/jcs.210724

Boysen, 2019, Hsp70- and Hsp90-Mediated Regulation of the Conformation of p53 DNA Binding Domain and p53 Cancer Variants, Mol. Cell, 74, 831, 10.1016/j.molcel.2019.03.032

Dahiya, 2019, Coordinated Conformational Processing of the Tumor Suppressor Protein p53 by the Hsp70 and Hsp90 Chaperone Machineries, Mol. Cell, 74, 816, 10.1016/j.molcel.2019.03.026

Han, 2008, AIMP2/p38, the scaffold for the multi-tRNA synthetase complex, responds to genotoxic stresses via p53, Proc. Natl. Acad. Sci. USA, 105, 11206, 10.1073/pnas.0800297105

Huang, 2003, Hypoxia-inducible Factor and Its Biomedical Relevance, J. Biol. Chem., 278, 19575, 10.1074/jbc.R200030200

Ryan, 1998, HIF-1 alpha is required for solid tumor formation and embryonic vascularization, EMBO J., 17, 3005, 10.1093/emboj/17.11.3005

Gordan, 2007, Hypoxia-inducible factors: Central regulators of the tumor phenotype, Curr. Opin. Genet. Dev., 17, 71, 10.1016/j.gde.2006.12.006

Zhou, 2004, PI3K/Akt Is Required for Heat Shock Proteins to Protect Hypoxia-inducible Factor 1 from pVHL-independent Degradation, J. Biol. Chem., 279, 13506, 10.1074/jbc.M310164200

Gabai, 2012, Heat Shock Transcription Factor Hsf1 Is Involved in Tumor Progression via Regulation of Hypoxia-Inducible Factor 1 and RNA-Binding Protein HuR, Mol. Cell. Biol., 32, 929, 10.1128/MCB.05921-11

Fan, 2003, Role of the RNA-binding protein HuR in colon carcinogenesis, Oncogene, 22, 7146, 10.1038/sj.onc.1206862

Kim, 2016, Heat shock protein 70-1A is a novel angiogenic regulator, Biochem. Biophys. Res. Commun., 469, 222, 10.1016/j.bbrc.2015.11.125

Park, 2017, HSP70-1 is required for interleukin-5-induced angiogenic responses through eNOS pathway, Sci. Rep., 7, 44687, 10.1038/srep44687

Kluger, 2005, Using a Xenograft Model of Human Breast Cancer Metastasis to Find Genes Associated with Clinically Aggressive Disease, Cancer Res., 65, 5578, 10.1158/0008-5472.CAN-05-0108

Teng, 2012, HSP90 and HSP70 Proteins Are Essential for Stabilization and Activation of WASF3 Metastasis-promoting Protein*, J. Biol. Chem., 287, 10051, 10.1074/jbc.M111.335000

Frisch, 1994, Disruption of epithelial cell-matrix interactions induces apoptosis, J. Cell Biol., 124, 619, 10.1083/jcb.124.4.619

Kasioumi, 2018, Hsp70 (HSP70A1A) downregulation enhances the metastatic ability of cancer cells, Int. J. Oncol., 54, 821

Mao, 2003, hsp72 Inhibits Focal Adhesion Kinase Degradation in ATP-depleted Renal Epithelial Cells, J. Biol. Chem., 278, 18214, 10.1074/jbc.M300126200

Jang, 2011, The C-terminus of Hsp70-Interacting Protein Promotes Met Receptor Degradation, J. Thorac. Oncol., 6, 679, 10.1097/JTO.0b013e31820d9c7e

Iii, 2009, Facilitating Akt Clearance via Manipulation of Hsp70 Activity and Levels*, J. Biol. Chem., 285, 2498

Li, H., Li, Y., Liu, D., Sun, H., Su, N., Yang, F., and Liu, J. (2013). Extracellular HSP70/HSP70-PCs Promote Epithelial-Mesenchymal Transition of Hepatocarcinoma Cells. PLoS ONE, 8.

Komarova, E., Marchenko, L., Zhakhov, A., Nikotina, A., Aksenov, N., Suezov, R., Ischenko, A., Margulis, B., and Guzhova, I.V. (2019). Extracellular Hsp70 Reduces the Pro-Tumor Capacity of Monocytes/Macrophages Co-Cultivated with Cancer Cells. Int. J. Mol. Sci., 21.

Mao, 2008, HSP72 attenuates renal tubular cell apoptosis and interstitial fibrosis in obstructive nephropathy, Am. J. Physiol. Physiol., 295, F202, 10.1152/ajprenal.00468.2007

Yun, 2010, Geldanamycin inhibits TGF-β signaling through induction of Hsp70, Arch. Biochem. Biophys., 495, 8, 10.1016/j.abb.2009.12.003

Li, 2011, HSP70 decreases receptor-dependent phosphorylation of Smad2 and blocks TGF-β-induced epithelial-mesenchymal transition, J. Genet. Genom., 38, 111, 10.1016/j.jgg.2011.02.001

Liu, 2014, HSP70 inhibits high glucose-induced Smad3 activation and attenuates epithelial-to-mesenchymal transition of peritoneal mesothelial cells, Mol. Med. Rep., 10, 1089, 10.3892/mmr.2014.2279

Jeon, 2017, MET: Roles in epithelial-mesenchymal transition and cancer stemness, Ann. Transl. Med., 5, 5, 10.21037/atm.2016.12.67

Chao, A., Lai, C.-H., Tsai, C.-L., Hsueh, S., Hsueh, C., Lin, C.-Y., Chou, H.-H., Lin, Y.-J., Chen, H.-W., and Chang, T.-C. (2013). Tumor Stress-Induced Phosphoprotein1 (STIP1) as a Prognostic Biomarker in Ovarian Cancer. PLoS ONE, 8.

Wang, 2014, Increased expression of stress inducible protein 1 in glioma-associated microglia/macrophages, J. Neuroimmunol., 274, 71, 10.1016/j.jneuroim.2014.06.021

Willmer, 2013, Knockdown of Hop downregulates RhoC expression, and decreases pseudopodia formation and migration in cancer cell lines, Cancer Lett., 328, 252, 10.1016/j.canlet.2012.09.021

Walsh, 2011, RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation, Cancer Lett., 306, 180, 10.1016/j.canlet.2011.03.004

Suzuki, 2011, BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells, Cancer Lett., 303, 65, 10.1016/j.canlet.2011.01.019

Lee, 2006, Release of heat shock protein 70 (Hsp70) and the effects of extracellular Hsp70 on matric metalloproteinase-9 expression in human monocytic U937 cells, Exp. Mol. Med., 38, 364, 10.1038/emm.2006.43

Chetty, 2011, MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells, Cell. Signal., 24, 549, 10.1016/j.cellsig.2011.10.008

Li, 2005, WAVE3-mediated Cell Migration and Lamellipodia Formation Are Regulated Downstream of Phosphatidylinositol 3-Kinase*, J. Biol. Chem., 280, 21748, 10.1074/jbc.M500503200

Teng, 2010, Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and metastases, Br. J. Cancer, 103, 1066, 10.1038/sj.bjc.6605850

Safina, 2007, Down-Regulation of WAVE3, a Metastasis Promoter Gene, Inhibits Invasion and Metastasis of Breast Cancer Cells, Am. J. Pathol., 170, 2112, 10.2353/ajpath.2007.060975

Breuninger, 2018, Membrane Hsp70—A Novel Target for the Isolation of Circulating Tumor Cells After Epithelial-to-Mesenchymal Transition, Front. Oncol., 8, 497, 10.3389/fonc.2018.00497

Farkas, 2003, Heat shock protein 70 membrane expression and melanoma-associated marker phenotype in primary and metastatic melanoma, Melanoma Res., 13, 147, 10.1097/00008390-200304000-00006

Botzler, 1998, Differential Hsp70 plasma-membrane expression on primary human tumors and metastases in mice with severe combined immunodeficiency, Int. J. Cancer, 77, 942, 10.1002/(SICI)1097-0215(19980911)77:6<942::AID-IJC25>3.0.CO;2-1

Jolly, 2015, Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis, Front. Oncol., 5, 155, 10.3389/fonc.2015.00155

Stangl, 2010, Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody, Proc. Natl. Acad. Sci. USA USA, 108, 733, 10.1073/pnas.1016065108

Williamson, 2009, Novel Adenosine-Derived Inhibitors of 70 kDa Heat Shock Protein, Discovered Through Structure-Based Design†, J. Med. Chem., 52, 1510, 10.1021/jm801627a

Macias, 2011, Adenosine-Derived Inhibitors of 78 kDa Glucose Regulated Protein (Grp78) ATPase: Insights into Isoform Selectivity, J. Med. Chem., 54, 4034, 10.1021/jm101625x

Li, 2015, Validation of the Hsp70-Bag3 protein-protein interaction as a potential therapeutic target in cancer, Mol. Cancer Ther., 14, 642, 10.1158/1535-7163.MCT-14-0650

Yaglom, 2018, Cancer cell responses to Hsp70 inhibitor JG-98: Comparison with Hsp90 inhibitors and finding synergistic drug combinations, Sci. Rep., 8, 3010, 10.1038/s41598-017-14900-0

Sherman, 2014, Hsp70 in cancer: Back to the future, Oncogene, 34, 4153, 10.1038/onc.2014.349

Koren, J., Miyata, Y., Kiray, J., O’Leary, J.C., Nguyen, L., Guo, J., Blair, L.J., Li, X., Jinwal, U.K., and Cheng, J.Q. (2012). Correction: Rhodacyanine Derivative Selectively Targets Cancer Cells and Overcomes Tamoxifen Resistance. PLoS ONE, 7.

Massey, 2009, A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells, Cancer Chemother. Pharmacol., 66, 535, 10.1007/s00280-009-1194-3

Deocaris, 2007, Mortalin sensitizes human cancer cells to MKT-077-induced senescence, Cancer Lett., 252, 259, 10.1016/j.canlet.2006.12.038

Leu, 2009, A Small Molecule Inhibitor of Inducible Heat Shock Protein 70, Mol. Cell, 36, 15, 10.1016/j.molcel.2009.09.023

Schmitt, 2006, Heat Shock Protein 70 Neutralization Exerts Potent Antitumor Effects in Animal Models of Colon Cancer and Melanoma, Cancer Res., 66, 4191, 10.1158/0008-5472.CAN-05-3778

Ernst, 2016, A novel Hsp70 inhibitor prevents cell intoxication with the actin ADP-ribosylating Clostridium perfringens iota toxin, Sci. Rep., 6, 20301, 10.1038/srep20301

Gobbo, 2011, Peptides and Aptamers Targeting HSP70: A Novel Approach for Anticancer Chemotherapy, Cancer Res., 71, 484, 10.1158/0008-5472.CAN-10-1443

Rodina, 2013, Identification of an Allosteric Pocket on Human Hsp70 Reveals a Mode of Inhibition of This Therapeutically Important Protein, Chem. Biol., 20, 1469, 10.1016/j.chembiol.2013.10.008

Williams, 2008, An Apoptosis-Inducing Small Molecule That Binds to Heat Shock Protein 70, Angew. Chem. Int. Ed., 47, 7466, 10.1002/anie.200802801

Ko, 2015, A Small Molecule Inhibitor of ATPase Activity of HSP70 Induces Apoptosis and Has Antitumor Activities, Chem. Biol., 22, 391, 10.1016/j.chembiol.2015.02.004

Braunstein, 2011, Antimyeloma Effects of the Heat Shock Protein 70 Molecular Chaperone Inhibitor MAL3-101, J. Oncol., 2011, 1, 10.1155/2011/232037

Fewell, 2004, Small Molecule Modulators of Endogenous and Co-chaperone-stimulated Hsp70 ATPase Activity, J. Biol. Chem., 279, 51131, 10.1074/jbc.M404857200

Huryn, 2011, Chemical methodology as a source of small-molecule checkpoint inhibitors and heat shock protein 70 (Hsp70) modulators, Proc. Natl. Acad. Sci. USA USA, 108, 6757, 10.1073/pnas.1015251108

Phillips, 2011, Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway, Cancer Lett., 308, 181, 10.1016/j.canlet.2011.05.002

Howe, 2014, Identification of an allosteric small-molecule inhibitor selective for the inducible form of heat shock protein 70, Chem. Biol., 21, 1648, 10.1016/j.chembiol.2014.10.016

Phillips, 2007, Triptolide Induces Pancreatic Cancer Cell Death via Inhibition of Heat Shock Protein 70, Cancer Res., 67, 9407, 10.1158/0008-5472.CAN-07-1077

Banerjee, 2013, Minnelide reduces tumor burden in preclinical models of osteosarcoma, Cancer Lett., 335, 412, 10.1016/j.canlet.2013.02.050

Antonoff, 2010, Role of Hsp-70 in Triptolide-Mediated Cell Death of Neuroblastoma, J. Surg. Res., 163, 72, 10.1016/j.jss.2010.04.047

MacKenzie, 2013, Triptolide induces the expression of miR-142-3p: A negative regulator of heat shock protein 70 and pancreatic cancer cell proliferation, Mol. Cancer Ther., 12, 1266, 10.1158/1535-7163.MCT-12-1231

Jacobson, 2015, Triptolide and its prodrug minnelide suppress Hsp70 and inhibit in vivo growth in a xenograft model of mesothelioma, Genes Cancer, 6, 144, 10.18632/genesandcancer.55

Rousalova, I., Banerjee, S., Sangwan, V., Evenson, K., McCauley, J.A., Kratzke, R., Vickers, S.M., Saluja, A.K., and D’Cunha, J. (2013). Minnelide: A Novel Therapeutic That Promotes Apoptosis in Non-Small Cell Lung Carcinoma In Vivo. PLoS ONE, 8.

Liu, 2011, Triptolide and its expanding multiple pharmacological functions, Int. Immunopharmacol., 11, 377, 10.1016/j.intimp.2011.01.012

Propper, D., Han, H., Von Hoff, D., Borazanci, E., Reya, T., Ghergurovich, J., Pshenichnaya, I., Antal, C., Condjella, R., and Sharma, S. (2019). Abstract CT165: Phase II open label trial of minnelide™ in patients with chemotherapy refractory metastatic pancreatic cancer. Clin. Trials.

Hung, 2012, Demethoxycurcumin Modulates Prostate Cancer Cell Proliferation via AMPK-Induced Down-regulation of HSP70 and EGFR, J. Agric. Food Chem., 60, 8427, 10.1021/jf302754w

Jung, 2010, Quercetin suppresses HeLa cell viability via AMPK-induced HSP70 and EGFR down-regulation, J. Cell. Physiol., 223, 408, 10.1002/jcp.22049

Choi, 2001, Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin, Int. J. Oncol., 19, 837

Milani, 2009, Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy—A case report, J. Transl. Med., 7, 50, 10.1186/1479-5876-7-50

Krause, 2004, Treatment of Colon and Lung Cancer Patients with ex Vivo Heat Shock Protein 70-Peptide-Activated, Autologous Natural Killer Cells: A Clinical Phase I Trial, Clin. Cancer Res., 10, 3699, 10.1158/1078-0432.CCR-03-0683

Trimble, 2009, A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3, Clin. Cancer Res., 15, 361, 10.1158/1078-0432.CCR-08-1725

Maeda, 2015, Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: A phase 1 dose escalation clinical trial, Cancer Immunol. Immunother., 64, 1047, 10.1007/s00262-015-1709-1

Kokowski, 2019, Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: A case study, Strahlenther. und Onkol., 195, 352, 10.1007/s00066-019-01434-9

Li, 2005, Combination of Imatinib Mesylate with Autologous Leukocyte-Derived Heat Shock Protein and Chronic Myelogenous Leukemia, Clin. Cancer Res., 11, 4460, 10.1158/1078-0432.CCR-05-0250

(2020, February 18). ClinicalTrials.gov, Available online: https://clinicaltrials.gov/ct2/show/study/NCT00058747?term=hsp70&draw=2&rank=20;.

Li, 2008, A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients, Gene Ther., 16, 376, 10.1038/gt.2008.179